Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSevere, sudden diarrhoea is one of the more distressing things people report in the early weeks on Wegovy. It is real, it is recognised, and it has a clear physiological explanation. Semaglutide slows how quickly food leaves your stomach and alters gut motility — changes that can produce loose, urgent stools, sometimes dramatically so, particularly after a dose increase. For most people this settles as the body adjusts, but knowing what to expect, and knowing when the pattern crosses into something that needs medical attention, makes a significant difference. Wegovy is a prescription-only weight-loss treatment and any concerns about how you're tolerating it should be part of an ongoing conversation with your prescribing team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy works partly by activating GLP-1 receptors in the gut, slowing gastric emptying and changing the pace at which digested material moves through the intestines. For most people, that slowing effect produces constipation early in treatment. For others (and the proportion is not small) the disruption runs the other way: the gut speeds up rather than slows, producing loose stools that arrive urgently and with little warning.
The NHS semaglutide information page lists diarrhoea as a common side effect, meaning it affects more than one in every hundred people using the medicine. "Explosive" or very urgent diarrhoea is a more intense version of the same mechanism, often triggered by fatty or rich food sitting in a slower-moving stomach before a faster-moving bowel. It tends to cluster in the first few weeks at any given dose and frequently eases once the body has adapted, though adaptation timelines vary considerably from person to person.
Dose increases are the most reliable trigger. If you stepped up recently and noticed the pattern starting within a day or two of the new dose, that timing is the explanation. It is worth reading the full side-effect profile for Wegovy so that what you are experiencing sits in context rather than arriving as a surprise.
A question our prescribers hear most weeks is whether anything can be taken during an acute episode to slow things down. The honest answer is: managing the episode is mostly about what you eat and drink rather than what you add.
Hydration is the priority. Repeated liquid stools deplete water and electrolytes quickly, and dehydration on top of a GLP-1 medicine can put unusual strain on the kidneys. Small, frequent sips of water or an oral rehydration solution are more effective than trying to drink large volumes at once. Plain, low-fat foods (toast, boiled rice, banana) tend to be better tolerated than anything heavy or fatty while symptoms are active.
Reducing portion size and cutting back on foods that are high in fat or fibre during a flare can also help, because both slow gastric emptying further and may worsen the gut's erratic response. The practical guide to managing diarrhoea on Wegovy covers dietary adjustments in more detail. Always check your Patient Information Leaflet for specific guidance on managing gastrointestinal symptoms, and raise any persistent pattern with your prescriber at the next review rather than adjusting your dose yourself.
Most Wegovy-related diarrhoea resolves without medical intervention. Some does not, and it matters to know the difference.
Get medical help promptly if any of the following apply: diarrhoea lasting more than 48 hours without clear improvement is one of the key signs that what you are experiencing has moved beyond ordinary gut adjustment; signs of dehydration you cannot correct by drinking (dizziness, very dark urine, feeling faint); blood in stools; severe cramping or abdominal pain. The last point is worth underlining. The MHRA's 2026 Drug Safety Update on GLP-1 medicines highlighted acute pancreatitis as a known, infrequent but serious risk: the distinguishing symptom is severe, persistent stomach pain that may travel to the back, sometimes accompanied by vomiting. That pattern (pain that does not settle, particularly radiating pain) is not a stomach bug. It needs urgent assessment, not paracetamol and a hot water bottle.
If you are unsure whether what you are experiencing is typical GI adjustment or something that warrants a call to your GP or 111, the safer assumption is always to check. Our support team is available seven days a week if you need to reach us between consultations. You can also report any suspected side effect directly through the MHRA Yellow Card scheme, which helps the regulator monitor real-world medicine safety.
For the majority of people, yes, and usually within a few weeks of settling at a given dose. The gut does adapt to semaglutide over time, and the severity of early gastrointestinal symptoms is rarely a guide to how someone will feel at three or six months. The STEP 1 trial, published in the New England Journal of Medicine, found that GI side effects were most common early in treatment and generally decreased over the study period, even as participants continued stepping up through the dose schedule.
If diarrhoea remains frequent and disruptive beyond four to six weeks at a stable dose, that conversation belongs in a clinical review. It may indicate that a slower titration pace would suit you better, or that a dose adjustment is warranted. A prescriber can also check whether anything else (a concurrent medication, a dietary pattern, or an unrelated gut condition) is amplifying the response. There is more detail on how diarrhoea fits into the broader side-effect picture of Wegovy, including what tends to drive it and how prescribers approach it, on the dedicated side effects page. There is more on how individual responses to semaglutide vary on the page covering whether Wegovy causes diarrhoea and what determines who is most affected.
If you have not yet started treatment and are weighing up the gastrointestinal side-effect profile before committing, our prescribers discuss exactly this as part of the free consultation, including what to watch for, and what to do if symptoms become difficult. You can speak to our prescribers and ask anything you need answered before you begin.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.